Long-term transcutaneous electrical nerve stimulation (TENS) use : Impact on medication utilization and physical therapy costs.
A study was conducted to assess a variety of treatment outcomes in long-term users of transcutaneous electrical nerve stimulation (TENS) who suffer from chronic pain.
Key components of the study examined the effects of long-term TENS therapy on pain-related medications and physical/occupational therapy (PT/OT) use.
From a population of 2,003 chronic pain patients (CPPs) who acquired a TENS device (Epix XL, Empi, Inc., St.
Paul, MN, U.S.A.) for pain management, a randomly selected sample of 376 patients who used TENS were interviewed by telephone by an independent research firm.
The survey assessed a variety of outcome variables including changes in medication use, number of pain-related medications, and use of PT/OT prior to TENS and after a minimum 6 months of TENS treatment.
The data were subjected to a paired t test analysis.
A cost simulation model was then applied to the medication and PT/OT data.
The mean duration of pain, for which TENS was prescribed. was 40 ± 60 months.
As compared with the period prior to TENS use, this long-term TENS user group reported a statistically significant reduction in the following types of pain medications : opiate analgesics, tranquilizers, muscle relaxants, nonsteroidal anti-inflammatory drugs (NSAIDs), and steroids.
PT/OT use was also significantly reduced.
Cost simulations of pain medications and PT/OT are presented. (...)
Mots-clés Pascal : Stimulus électrique, Nerf périphérique, Voie percutanée, Douleur, Chronique, Analyse coût efficacité, Chimiothérapie, Analgésique, Traitement physique, Etats Unis, Amérique du Nord, Amérique, Economie santé, Traitement instrumental, Long terme, Impact économique, Homme
Mots-clés Pascal anglais : Electrical stimulus, Peripheral nerve, Percutaneous route, Pain, Chronic, Cost efficiency analysis, Chemotherapy, Analgesic, Physical dressing, United States, North America, America, Health economy, Instrumentation therapy, Long term, Economic impact, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0177524
Code Inist : 002B26I. Création : 11/09/1998.